Post-earnings recap
Reported
Wed, Aug 5, 2026
EPS actual
$9.93
EPS est.
$9.44
EPS surprise
+5.25%
1-day move
+5.64%
McKesson's strong EPS performance, exceeding expectations by 5.25%, contributed to a positive stock reaction, with shares rising 5.64%. However, the lack of revenue data and guidance leaves some uncertainty about future performance. Investors may be encouraged by the earnings beat but will be looking for more information in future reports.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $9.93 | N/A | +5.25% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.
McKesson Corporation is a leading health care distributor that plays a crucial role in the supply chain by delivering pharmaceuticals and medical supplies to hospitals, pharmacies, and other health care providers. As a major player in the health care sector, McKesson's performance can reflect broader trends in health care spending and the impact of regulatory changes.
Last quarter
In Q4-2026, McKesson reported an earnings per share (EPS) of $11.69, which was slightly above analysts' expectations. The stock reacted positively, gaining 1.49% the following day.
Management promises and guidance
EPS beat streak
4Q
EPS beat rate
75%
Avg EPS surprise
+2.66%
Avg 1-day reaction
+0.49%
Overall, Wall Street is cautiously optimistic about McKesson's upcoming earnings report, given its recent performance and the stability of the health care sector. However, there are concerns about potential revenue pressures due to market competition.
Bull case
If McKesson can demonstrate strong revenue growth and maintain or improve its operating margins, it could signal robust demand for its services and a solid outlook for the future.
Bear case
On the other hand, if the company reports disappointing earnings or guidance, it could raise concerns about its ability to compete effectively in a challenging market.
The print will turn on these.
Q1
What is the expected EPS for this quarter, and how does it compare to last quarter's performance?
The EPS figure will be a key indicator of McKesson's profitability and could significantly influence investor sentiment.
Q2
How is McKesson addressing competitive pressures in the health care distribution market?
Understanding the company's strategy to maintain or grow its market share will be crucial for assessing its future growth potential.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±12.7%
Why consensus could be wrong
The Street may be underestimating McKesson's ability to leverage its scale and efficiency to drive profitability despite competitive pressures.
Supporting evidence
McKesson has consistently beaten EPS estimates in 75% of the last eight quarters.
The options market is pricing in a larger move than historical averages, indicating potential for a surprise.
Recent trends in health care spending may favor established distributors like McKesson.
Key risk
If McKesson's EPS comes in above $12.00, it could challenge the current cautious outlook.
Pre-commit to what would confirm each case.
This quarter's performance will hinge on McKesson's ability to navigate competitive pressures and deliver solid financial results.
Bull confirmed if
If McKesson reports an EPS of $12.00 or higher, it would confirm strong operational performance and market demand.
Bear confirmed if
An EPS below $10.50 would raise concerns about the company's ability to compete effectively.
What the market is pricing for the move.
Implied Move
±5.6%
Historical Avg
±2.7%
The options market is pricing in a significant move of about 5.6%, suggesting that traders expect volatility around the earnings report.
Options are pricing ±5.6% while MCK has averaged ±2.7% over the last 8 prints — setup is pricing rich.
ATM IV
0.3%
30d HV
28.8%
Smart-money positioning from the most recent 13F filings.
Institutional
93.57%
of float
Insider
0.06%
of float
Holders
2,662
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
10,795,054 sh · $9.8B
9.26%
-5.5%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If McKesson beats expectations, history suggests the stock could rise by around 3.1% on the first day, confirming strong operational health.
In line / cautious
If results are in line but management provides cautious guidance, the stock may see muted movement as investors weigh future prospects.
Miss
Should the company miss expectations, history suggests a potential decline of about 0.11%, reflecting investor disappointment.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
2
1 buy·1 sell
Members
2
House only
Est. Notional
$2,002.00–$30,000.00
disclosed dollar ranges
Most Active Members
1 trade
The lines on the call that would change the story.
Vanguard Capital Management LLC
7,853,137 sh · $7.1B
6.74%
-1.4%
State Street Corporation
5,727,118 sh · $5.2B
4.91%
-0.1%
Morgan Stanley
5,306,142 sh · $4.8B
4.55%
130.7%
Franklin Resources, Inc.
2,905,114 sh · $2.6B
2.49%
-5.2%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Net buying
1 trade
Net selling
Recent Transactions
Traded Jul 8, 2026 · disclosed Jul 12, 2026
$1,001.00–$15,000.00
Traded Jun 15, 2026 · disclosed Jul 15, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.